• Bradykinin (BA5201): Workflow Guidance for Vasodilator Resea

  2026-07-06

  Bradykinin (SKU BA5201) addresses key needs in cardiovascular, inflammation, and pain mechanism research by enabling controlled studies of endothelium-dependent vasodilation and vascular permeability. It is not suitable for diagnostic or therapeutic use, and strict handling protocols are necessary to maintain reagent integrity.

• SNS-032 (BMS-387032): Precision CDK Inhibition in Cancer & A

  2026-07-05

  SNS-032 (BMS-387032) stands out as a selective cyclin-dependent kinase inhibitor, enabling researchers to dissect cell cycle and transcriptional control in both oncology and antiviral contexts. From apoptosis induction in cancer cells to blocking SARS-CoV-2 release, it delivers protocol-ready precision for transformative bench applications.

• SM-102 in Lipid Nanoparticles: Transforming mRNA Delivery

  2026-07-04

  SM-102 empowers researchers to design high-efficiency mRNA delivery systems, enabling targeted therapies from cancer to vaccines. Discover protocol enhancements, troubleshooting strategies, and practical insights directly informed by cutting-edge literature—ensuring your lipid nanoparticle workflows are robust, reproducible, and ready for translation.

• EPZ5676: A Strategic DOT1L Inhibitor for Translational Epige

  2026-07-03

  This thought-leadership article explores the mechanistic rationale, translational evidence, and workflow strategies for targeting DOT1L with EPZ5676—spotlighting its unique value for researchers in leukemia and fibrosis. Drawing on recent findings and advanced protocol guidance, it sets a new agenda for translational epigenetics beyond conventional applications.

• Octenidine (dihydrochloride): Reliable Antiseptic for Lab As

  2026-07-03

  This article addresses key laboratory challenges in cell viability and antimicrobial research, demonstrating how Octenidine (dihydrochloride) (SKU C6432) from APExBIO achieves reproducible, high-purity results. Scenario-driven Q&A blocks provide practical guidance on experimental design, protocol optimization, data interpretation, and product selection for scientists seeking robust chemical antiseptics.

• Angiotensin 1/2 (1-6): Precision Control in RAS-Driven Assay

  2026-07-02

  Angiotensin 1/2 (1-6) is a potent tool for dissecting renin-angiotensin system mechanisms and vascular tone modulation. Discover how this Asp-Arg-Val-Tyr-Ile-His hexapeptide enables more precise, reproducible cardiovascular and viral pathophysiology research.

• Biotin-Free Proximity Labeling in Primary T Cells with BmTyr

  2026-07-02

  This study introduces a copper-dependent BmTyr-based platform for biotin-free, click-compatible proximity labeling in primary T cells. By enabling sensitive, context-specific proteomic mapping without background interference from endogenous biotin, the platform advances the study of subcellular protein networks in challenging primary cell models.

• Carvacrol in Advanced Redox Signaling and Ion Channel Resear

  2026-07-01

  Explore the multifaceted role of Carvacrol in redox biology and TRP ion channel modulation. This in-depth analysis reveals new insights for cell cycle research, building on recent discoveries in singlet oxygen signaling.

• Rhodamine B as a Translational Tool: Precision Fluorescence

  2026-07-01

  This article explores the mechanistic underpinnings and strategic deployment of Rhodamine B (Basic Violet 10) as a high-performance fluorescent probe for microscopy and translational research. Integrating insights from recent nanomedicine advances and environmental tracing, we unveil how APExBIO's Rhodamine B drives reproducibility—bridging cell biology, quantitative assay development, and cutting-edge therapeutic monitoring. With evidence from both reference studies and cross-domain protocols, we offer actionable guidance for researchers seeking to elevate sensitivity and reliability in complex biological systems.

• D-Luciferin in Next-Gen Immuno-Oncology: Beyond Imaging

  2026-06-30

  Explore the evolving scientific role of D-Luciferin as a firefly luciferase substrate in immuno-oncology. This article reveals how D-Luciferin underpins advanced tumor immunity research, bridging promoter-driven gene expression monitoring with actionable translational applications.

• STING Agonist-1: Translational Impact in B Cell Immunity Res

  2026-06-30

  Discover how STING agonist-1 enables advanced exploration of B cell-driven immunity in cancer and inflammation research. This in-depth article uniquely connects mechanistic breakthroughs to practical assay design, optimizing the use of this immunology research reagent.

• Large-Scale Gastruloid Arrays Enable High-Throughput Phenoty

  2026-06-29

  Jan et al. introduce a scalable microraft array platform for the parallel imaging, analysis, and sorting of hundreds of human gastruloids, allowing systematic identification of aberrant developmental phenotypes. This technology provides a robust foundation for dissecting single-gastruloid heterogeneity and gene expression, with direct implications for developmental biology and disease modeling.

• Carbapenemase Gene Transmission in CREC: Genomic and Epidemi

  2026-06-29

  This study delivers a detailed genomic and epidemiological mapping of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China during the COVID-19 era. The findings elucidate the prevalence, transmission dynamics, and clinical implications of blaNDM-1 and other CEGs, offering critical data for antibiotic resistance research and infection control strategies.

• Cell lysis buffer for WB and IP: Precision in Tumor Microenv

  2026-06-28

  Unlock robust, non-denaturing protein extraction for Western blot and immunoprecipitation with Cell lysis buffer for WB and IP. This APExBIO solution, fortified with a comprehensive protease and phosphatase inhibitor cocktail, empowers researchers to dissect tumor microenvironment mechanisms—minimizing protein degradation and maximizing data reliability across diverse biological models.

• 25-Hydroxycholesterol Reprograms Macrophages via Lysosomal A

  2026-06-27

  Xiao et al. (2024) reveal how 25-hydroxycholesterol (25HC), produced by CH25H, accumulates in lysosomes of tumor-associated macrophages to activate the AMPKa pathway and drive immunosuppression. This mechanistic insight links cholesterol metabolism to immune cell fate and suggests new immunometabolic checkpoints and therapeutic strategies for cancer.

447 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page